RxDoctor Payments Data

Kimberly Webb

Gerontology · Wyandotte, MINPI 1700490216

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 51 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Johnson & Johnson at 36.2% of the total. 2025 is the largest year on record at $700, more than ten times the $52 reported in 2021.

$1,780in general payments, 2019–2025

Across 51 payments — averaging $34.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$644
  • AstraZeneca$264
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$123
  • Teva Pharmaceuticals USA, Inc.$121
  • Luye Pharma (USA) Ltd.$89
  • Axsome Therapeutics, Inc.$89
  • plus $450 from 15 others

What the payments were for

  • Food & beverage$1,780100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,780 in reported general payments places this provider in the 75th percentile of 279 gerontology providers in Michigan.

See all gerontology providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban28$23,891
EntrestoSacubitril/Valsartan11$7,262
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$3,977
Sucralfate12$1,594
Atorvastatin Calcium65$1,075
Omeprazole29$534
Losartan Potassium42$457
Duloxetine Hcl18$418
Albuterol Sulfate HfaAlbuterol Sulfate11$412
Levothyroxine Sodium38$392
Pantoprazole Sodium35$353
Metoprolol Succinate24$313
Tamsulosin Hcl15$251
Gabapentin23$245
Carvedilol27$225

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$20$23,89128 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 279 gerontology providers in Michigan.

Other gerontology in Wyandotte

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →